Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aytu Biopharma Inc (NQ: AYTU )

0.5193 -0.0028 (-0.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 581,101
Open 0.5200
Bid (Size) 0.5194 (18)
Ask (Size) 0.5200 (47)
Prev. Close 0.5221
Today's Range 0.5110 - 0.5390
52wk Range 0.4500 - 5.380
Shares Outstanding 38,574,875
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aytu BioPharma to Participate in the Lytham Partners Summer 2022 Investor Conference
ENGLEWOOD, CO / ACCESSWIRE / June 13, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that the company... 
From Aytu BioPharma, Inc.
Via AccessWire
Aytu BioPharma Plans To Divest / Discontinue Non Core Assets
 
Via Benzinga

Performance

YTD
-66.50%
-66.50%
1 Month
-9.18%
-9.18%
3 Month
-53.63%
-53.63%
6 Month
-64.91%
-64.91%
1 Year
-89.99%
-89.99%

More News

Read More
Aytu BioPharma: Q3 Earnings Insights
Via Benzinga
Aytu BioPharma Reports Third Quarter 2022 Financial Results and Outlines Key Strategic Priorities
From Aytu BioPharma, Inc.
Via AccessWire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Aytu BioPharma Announces Positive Preclinical Data in Ventilator-Associated Pneumonia with its Novel, Proprietary Healight(TM) Delivery Technology
From Aytu BioPharma, Inc.
Via AccessWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
54 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Aytu BioPharma Announces Fast Track Designation Granted to AR101 for the Treatment of Vascular Ehlers-Danlos Syndrome
From Aytu BioPharma, Inc.
Via AccessWire
Exposures Product Safety
Aytu BioPharma Announces FDA Orange Book Listing of Newly Issued Patent for Cotempla XR-ODT(R)
From Aytu BioPharma, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Aytu BioPharma to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
From Aytu BioPharma, Inc.
Via AccessWire
Aytu BioPharma to Participate in the 34th Annual Roth Conference
From Aytu BioPharma, Inc.
Via AccessWire
Aytu BioPharma Announces Closing of $7.6 Million Registered Offering
From Aytu BioPharma, Inc.
Via AccessWire
Aytu BioPharma Announces Pricing of $7.6 Million Registered Offering
From Aytu BioPharma, Inc.
Via AccessWire
Aytu BioPharma Announces AR101 Granted Orphan Designation in Europe for the Treatment of Ehlers-Danlos Syndrome
From Aytu BioPharma, Inc.
Via AccessWire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Aytu BioScience's Return On Capital Employed Overview
Via Benzinga
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
Via Benzinga
Aytu BioPharma Announces Business and Pipeline Progress and Reports Second Quarter 2022 Financial Results
From Aytu BioPharma, Inc.
Via AccessWire
Aytu BioScience, Inc. (NASDAQ:AYTU) Investor Alert: Investigation over Possible Violations of Securities Laws
Via SBWire
Aytu BioPharma Completes $15 Million Debt Refinancing
From Aytu BioPharma, Inc.
Via AccessWire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.